Sponsor Pipeline

Sapience Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
0
Recruiting
5
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-27 NCT07729371 A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT04478279 A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors Glioblastoma Active, Not Recruiting
Phase 1
NCT05848739 A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors Colon Cancer Active, Not Recruiting
NCT07729371 A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP). Familial Adenomatous Polyposis (FAP) Not Yet Recruiting
Disease Areas
Breast Cancer (1) Prostate Cancer (1) Melanoma (1) Glioblastoma (1) Colorectal Cancer (1)
Get alerts when Sapience Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free